120 related articles for article (PubMed ID: 10478989)
1. Azithromycin versus erythromycin for community-acquired pneumonia: a cost-minimization analysis.
Howard KB; Blumenschein K; Rapp RP
Am J Health Syst Pharm; 1999 Aug; 56(15):1521-4. PubMed ID: 10478989
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of IV-to-oral switch therapy: azithromycin vs cefuroxime with or without erythromycin for the treatment of community-acquired pneumonia.
Paladino JA; Gudgel LD; Forrest A; Niederman MS
Chest; 2002 Oct; 122(4):1271-9. PubMed ID: 12377852
[TBL] [Abstract][Full Text] [Related]
3. Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study.
Tamm M; Todisco T; Feldman C; Garbino J; Blasi F; Hogan P; de Caprariis PJ; Hoepelman IM
Clin Microbiol Infect; 2007 Feb; 13(2):162-171. PubMed ID: 17328728
[TBL] [Abstract][Full Text] [Related]
4. An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care.
Skrepnek GH; Armstrong EP; Malone DC; Ramachandran S
Curr Med Res Opin; 2005 Feb; 21(2):261-70. PubMed ID: 15801997
[TBL] [Abstract][Full Text] [Related]
5. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial.
Vergis EN; Indorf A; File TM; Phillips J; Bates J; Tan J; Sarosi GA; Grayston JT; Summersgill J; YU VL
Arch Intern Med; 2000 May; 160(9):1294-300. PubMed ID: 10809032
[TBL] [Abstract][Full Text] [Related]
6. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA
Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
[TBL] [Abstract][Full Text] [Related]
7. Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections.
Roord JJ; Wolf BH; Gossens MM; Kimpen JL
Antimicrob Agents Chemother; 1996 Dec; 40(12):2765-8. PubMed ID: 9124837
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in outpatient treatment of community-acquired pneumonia.
Najib MM; Stein GE; Goss TF
Pharmacotherapy; 2000 Apr; 20(4):461-9. PubMed ID: 10772376
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. The Azithromycin Intravenous Clinical Trials Group.
Plouffe J; Schwartz DB; Kolokathis A; Sherman BW; Arnow PM; Gezon JA; Suh B; Anzuetto A; Greenberg RN; Niederman M; Paladino JA; Ramirez JA; Inverso J; Knirsch CA
Antimicrob Agents Chemother; 2000 Jul; 44(7):1796-802. PubMed ID: 10858333
[TBL] [Abstract][Full Text] [Related]
10. A cost-minimization analysis comparing azithromycin-based and levofloxacin-based protocols for the treatment of patients hospitalized with community-acquired pneumonia: results from the CAP-IN trial.
Samsa GP; Matchar DB; Harnett J; Wilson J
Chest; 2005 Nov; 128(5):3246-54. PubMed ID: 16304269
[TBL] [Abstract][Full Text] [Related]
11. Is azithromycin monotherapy as efficacious as cefuroxime plus erythromycin for the treatment of community-acquired pneumonia in hospitalized patients?
See S
J Fam Pract; 2000 Oct; 49(10):883-4. PubMed ID: 11052155
[No Abstract] [Full Text] [Related]
12. Efficacy of erythromycin compared to clarithromycin and azithromycin in adults or adolescents with community-acquired pneumonia: A Systematic Review and meta-analysis of randomized controlled trials.
Ashy N; Alharbi L; Alkhamisi R; Alradadi R; Eljaaly K
J Infect Chemother; 2022 Aug; 28(8):1148-1152. PubMed ID: 35523718
[TBL] [Abstract][Full Text] [Related]
13. Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital.
Feldman RB; Rhew DC; Wong JY; Charles RA; Goetz MB;
Arch Intern Med; 2003 Jul; 163(14):1718-26. PubMed ID: 12885688
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia.
Bohte R; van't Wout JW; Lobatto S; Blussé van Oud Alblas A; Boekhout M; Nauta EH; Hermans J; van den Broek PJ
Eur J Clin Microbiol Infect Dis; 1995 Mar; 14(3):182-7. PubMed ID: 7614957
[TBL] [Abstract][Full Text] [Related]
15. Azithromycin versus comparative therapy for the treatment of community acquired pneumonia.
Rahav G; Fidel J; Gibor Y; Shapiro M
Int J Antimicrob Agents; 2004 Aug; 24(2):181-4. PubMed ID: 15288319
[TBL] [Abstract][Full Text] [Related]
16. [Antibiotic therapy of severe community-acquired pneumonia].
Molchanova OV; Suleĭmanov SSh; Ostrovskiĭ AB
Antibiot Khimioter; 2009; 54(3-4):29-31. PubMed ID: 19711847
[TBL] [Abstract][Full Text] [Related]
17. Single antibiotic therapy as effective as dual in treating patients hospitalized with community acquired pneumonia.
Rollins G
Rep Med Guidel Outcomes Res; 2000 Aug; 11(16):6-8. PubMed ID: 11799995
[No Abstract] [Full Text] [Related]
18. Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials.
Pitsouni E; Iavazzo C; Athanasiou S; Falagas ME
Int J Antimicrob Agents; 2007 Sep; 30(3):213-21. PubMed ID: 17596917
[TBL] [Abstract][Full Text] [Related]
19. Relationship between time to clinical response and outcomes among Pneumonia Outcomes Research Team (PORT) risk class III and IV hospitalized patients with community-acquired pneumonia who received ceftriaxone and azithromycin.
Zasowski E; Butterfield JM; McNutt LA; Cohen J; Cosler L; Pai MP; Gottwald J; Chen WZ; Lodise TP
Antimicrob Agents Chemother; 2014 Jul; 58(7):3804-13. PubMed ID: 24752270
[TBL] [Abstract][Full Text] [Related]
20. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
